Bengaluru-based Anthem Biosciences' initial public offering (IPO) has been subscribed nearly 10 times on its final day, indicating a 27% listing premium.

Anthem Biosciences is selling its shares in the price band of Rs 540-570, applied for a minimum of 26 shares and its ...

Anthem Biosciences' IPO is seeing huge demand on its last day. The issue has been subscribed 1,400% so far, showing strong interest from all types of investors. At the same time, the GMP has jumped to ...

Anthem Biosciences IPO GMP surged on Wednesday as the Rs 3,395-crore initial share saw robust subscription on the concluding ...

Anthem Biosciences Ltd, a CRDMO founded in 2006, offers end-to-end drug discovery-to-manufacturing services and specialises ...

Check latest subscription status, grey market premium (GMP), allotment date, listing date, and other key details here ...

Anthem Biosciences is raising ₹3,395 crore through an initial share sale, which comprises of entirely an offer-for-sale by ...

The IPO attracted strong interest, receiving bids for 17.66 crore shares against 4.4 crore shares on offer. Non-institutional ...

Today is the last day for investors to subscribe for the Anthem Biosciences IPO, which so far has gathered a lot of attention ...

The initial public offering of Anthem Biosciences Ltd. has been subscribed to nearly eight times the offer on its third and ...

Anthem Biosciences, ₹3,395 crore IPO was fully subscribed by Day 2, with strong interest from non-institutional investors, ...